Stay updated on Bumetanide Oral Liquid in ASD Children Clinical Trial
Sign up to get notified when there's something new on the Bumetanide Oral Liquid in ASD Children Clinical Trial page.

Latest updates to the Bumetanide Oral Liquid in ASD Children Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA notice about NIH website terminology and transition updates appears above the page, and the site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record. A Home link is shown, indicating the resource is temporarily unavailable or access-restricted.SummaryDifference19%

- Check47 days agoChange DetectedAdded a new revision label v3.7.0 replacing the previous v3.6.6 in the study record. This reflects an update to the page's versioning metadata rather than substantive changes to the study details.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision number on the page updated from v3.6.5 to v3.6.6, indicating a software update to the site. There is no indication of changes to study content or data in this update.SummaryDifference0.0%

- Check68 days agoChange DetectedA new NIH funding reference (2017) was added to the study's identifiers, indicating funding information associated with the trial.SummaryDifference0.0%

Stay in the know with updates to Bumetanide Oral Liquid in ASD Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bumetanide Oral Liquid in ASD Children Clinical Trial page.